Commentary
Journal of Investigative Dermatology (2007) 127, 2709–2710. doi:10.1038/sj.jid.5701129
Chronic Medication Use and Inflammatory Skin Diseases: The Power and Limitations of the Case–Control Study
Robert S Stern1
1Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Correspondence: Dr Robert S Stern, Department of Dermatology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, GZ522, Boston, Massachusetts 02215, USA. E-mail: rstern@bidmc.harvard.edu
Abstract
The potential of newly introduced medications to cause acute inflammatory skin diseases has long been recognized. Less well accepted and not often systematically studied is the role of long-term drug use in inflammatory skin diseases such as eczema. Hypothesis-driven case–control studies provide what is probably the most efficient but far from easy method to evaluate and quantify observations from case reports and case series that suggest a drug etiology for chronic skin diseases.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
How pre-B cells know when they have it rightNature Immunology News and Views (01 Sep 2003)



